Not a huge deal imo. Compared to todays volume and news, this amount of dilution should be fully absorbed tomorrow...then up she goes. It basically gives short sellers a 2nd chance to cover at this level if they didnt do so today.
I could be wrong and often am but I think the news on the FDA front overwhelms the selling on the companies part.
No, its not good at all. Small bio's do this all the time to stay afloat an continue operations. Recovery is usually slow on the share price unless a positive event happens soon after.
News 
Market Data 
Discover 
